Ernexa Therapeutics (ERNAW) Amortizatization of Intangibles (2019 - 2026)
Ernexa Therapeutics' (ERNAW) quarterly Amortizatization of Intangibles came in at $74000.0 in Q4 2019, up 1.37% on a QoQ basis from $73000.0 in Q3 2019.
Powered by 
Analysis
Ernexa Therapeutics (ERNAW) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Ernexa Therapeutics (ERNAW) has 1 years of Amortizatization of Intangibles data on file, last reported at $74000.0 in Q4 2019.
- Quarterly Amortizatization of Intangibles changed N/A year-over-year to $74000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $291000.0 (changed N/A YoY) and the FY2019 annual result came in at $291000.0, changed N/A from the prior year.
- Amortizatization of Intangibles rose to $74000.0 in Q4 2019, from $73000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $74000.0 in Q4 2019 to a low of $72000.0 in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Ernexa Therapeutics | 67,312.70 | 67,312.70 | - | 35,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35,000.00 |
| Mar 31, 2026 | 78,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 414,000.00 |
| Jun 30, 2024 | 534,000.00 |
| Mar 31, 2024 | 502,000.00 |
| Dec 31, 2023 | 459,000.00 |
| Sep 30, 2023 | 497,000.00 |
| Jun 30, 2023 | 42,000.00 |
| Mar 31, 2023 | 41,000.00 |
| Dec 31, 2022 | 69,000.00 |
| Sep 30, 2022 | 81,000.00 |
| Jun 30, 2022 | 84,000.00 |
| Mar 31, 2022 | 102,000.00 |
| Dec 31, 2021 | 99,000.00 |
| Sep 30, 2021 | 94,000.00 |